Epigenomics is Diagnostic Equipment in Germany that focus on information technology bases business. Founded in 1998. They cover business area such as Epigenomics AG, in vitro diagnostic liquid biopsy test, early detection, diagnosis, cancer, market procedure, device, quantity, particular epigenetic parameter, dna methylation pattern, their procurement, evaluation, novel molecular diagnostic product, Epi procolon, Epi biskit, Europe, Asia, North America.
1998
( 26 years old in 2024 )
Information Technology Bases
-
Geneststraße 5
10829 Berlin
Germany
Private
Epigenomics AGin vitro diagnostic liquid biopsy testearly detectiondiagnosiscancermarket proceduredevicequantityparticular epigenetic parameterdna methylation patterntheir procurementevaluationnovel molecular diagnostic productEpi procolonEpi biskitEuropeAsiaNorth America
* We use standard office opening hours in near Epigenomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Epigenomics is Diagnostic Equipment business from Germany that founded in 1998 (26 years old in 2024), Epigenomics business is focusing on Information Technology Bases.
Epigenomics headquarter office and corporate office address is located in Geneststraße 5 10829 Berlin Germany.
Epigenomics was founded in Germany.
In 2024, Epigenomics is currently focus on information technology bases sector.
Above is snippet of Google Trends for "information technology bases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Epigenomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
